GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brasil Pharma SA (BSP:BPHA3) » Definitions » Intangible Assets

Brasil Pharma (BSP:BPHA3) Intangible Assets : R$0.00 Mil (As of Mar. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Brasil Pharma Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Brasil Pharma's intangible assets for the quarter that ended in Mar. 2019 was R$0.00 Mil.


Brasil Pharma Intangible Assets Historical Data

The historical data trend for Brasil Pharma's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brasil Pharma Intangible Assets Chart

Brasil Pharma Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Intangible Assets
Get a 7-Day Free Trial Premium Member Only 1,341.63 1,141.73 897.34 3.32 -

Brasil Pharma Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Intangible Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Brasil Pharma Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.


Brasil Pharma  (BSP:BPHA3) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Brasil Pharma Intangible Assets Related Terms

Thank you for viewing the detailed overview of Brasil Pharma's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Brasil Pharma (BSP:BPHA3) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Presidente Juscelino Kubitschek, 1,830, 3rd floor, Itaim Bibi, Sao Paulo, SP, BRA, 04543-900
Brasil Pharma SA is a Brazil-based company primarily engaged in the pharmaceutical retail sector. The company operates in the retail sale of medicines, perfumes, cosmetics, skincare and beauty products and toiletries. The operating segments of the company are Retail sector and Service sector, of which majority of the revenue is generated from the Retail segment. The group has its presence in all the regions of Brazil through its own stores and a franchise network. The owned stores of the company are operated under the Big Ben, Guararapes, District Pharmacy Rosary, Sant'Ana and Mais Economica brands. The company's franchises operate under the Farmais brand.

Brasil Pharma (BSP:BPHA3) Headlines

No Headlines